UCB has a deep heritage in neurology, providing a range of solutions for people living with neurological disorders, including epilepsy and Parkinson’s disease. We are committed to expanding our leadership and capabilities into new frontiers with substantial unmet needs.
At UCB, we embrace the possibility to create a world free from the burden of immune-mediated inflammatory diseases. Relapsing and remitting in nature, these diseases place a huge strain on patients and their support systems. While there have been advancements in recent years, significant unmet needs remain.
Clinical studies involving healthy volunteers and patients play a vital role in the development of new drugs. These studies are conducted to ensure that all investigational drugs are safe and effective. Over recent years, along with drug discovery, drug development and clinical studies have benefitted from scientific and technological advancements as well as a greater understanding of the needs clinical study participants have.
